# OncoResponse

OncoResponse is an Asset Manager based in Houston, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Houston, United States
- **Region:** North America
- **Address:** Houston, TX, United States
- **Assets under management:** Undisclosed
- **Website:** oncoresponse.com
- **LinkedIn:** https://www.linkedin.com/company/oncoresponse

## Regulatory record

- **Reports private funds:** No

## About

OncoResponse, a Houston-based company, was founded in 2015. It focuses on cancer research, particularly immunotherapies and oncology technologies. The company has secured $137 million in total funding.

## Sectors

- Biotech
- Oncology

## Offices

- Seattle, WA, United States

## Questions

### What technology does OncoResponse use to discover antibodies?

OncoResponse uses a clinically validated technology platform that isolates authentic human antibodies from B cells of patients who achieved exceptional responses to checkpoint inhibitor therapy (per the firm's website). These antibodies target multiple immunosuppressive myeloid biology targets associated with the tumor microenvironment.

### What is the investment stage and structure of OncoResponse?

OncoResponse is a biotech company, not a fund or family office. It is structured to develop its own pipeline of monoclonal antibodies through preclinical research and clinical studies. The firm's financial details, investor base, and funding rounds are not publicly disclosed.

### Does OncoResponse collaborate with external partners?

The firm states it makes advancements through collaborators and strategic partnerships, listing current collaborators on its website. However, specific partner names or collaboration details are not publicly available beyond general references.

### What is the therapeutic focus of OncoResponse's pipeline?

OnocResponse's pipeline targets immunosuppressive myeloid biology in the tumor microenvironment. The firm aims to remove brakes on immune cells and convert cold tumors into hot tumors that respond to immunotherapy (per the firm's website).

### Who leads OncoResponse?

OncoResponse does not publicly name its leadership team, board of directors, or scientific advisory board members on its website. The firm's principals and organizational leadership remain undisclosed in public materials.

### Where does OncoResponse operate?

OncoResponse maintains headquarters in Houston, Texas, and has an additional office in Seattle, Washington (per the firm's website). All operations are within the United States.

## Related profiles

- [Sansiri](https://altss.com/profile/sansiri)
- [MD Anderson](https://altss.com/profile/md-anderson)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/oncoresponse

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology